Neurodegenerative Diseases: all 436 studies
Page 5 of 5. Open to participants first (143), then studies with results posted, then the rest; newest registration first within each.
- To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's PatientsCompletedNCT01023685Phase 2
- Shanghai Parkinson's StudyCompletedNCT00999388
- To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's PatientsCompletedNCT00956410Phase 2
- Ferrochelating Treatment in Patients Affected by Neurodegeneration With Brain Iron Accumulation (NBIA)Status unknownNCT00907283Phase 2
- Effects of Chocolate on Motor Symptoms of Parkinson's DiseaseStatus unknownNCT00906763Not applicable
- Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on DonepezilCompletedNCT00829374Phase 3
- Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's PatientsCompletedNCT00795418Phase 2
- Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Mild Alzheimer's Patients.CompletedNCT00733863Phase 2
- Comparing The Cyberlink Control System to the Manual Letter Board for Communication Purposes in the ALS Patient PopulationCompletedNCT00718497
- EEG-Based Brain-Computer Interface Project for Individuals With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00718458
- Pennsylvania Consortium: Clinical DatabaseTerminatedNCT00718445
- Compassionate Use of Ceftriaxone in Patients With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00718393
- Satisfaction Survey for Amyotrophic Lateral Sclerosis (ALS) Patients Comparing Rooms With and Without Assistive TechnologyTerminatedNCT00718107
- Assessment of the Cyberlink Control System for Use by the Amyotrophic Lateral Sclerosis (ALS) PatientTerminatedNCT00718016
- Noninvasive Examination of the Work of Breathing in Patients With Amyotrophic Lateral Sclerosis (ALS).TerminatedNCT00718003
- Amyotrophic Lateral Sclerosis (ALS) Tissue Donation ProgramCompletedNCT00716131
- Non-Invasive Measurement of Gastrointestinal (GI) Motility in Patients With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00714805
- Cerebrospinal Fluid RepositoryCompletedNCT00714636
- Quantitative Measurement of Nutritional Substrate Utilization in Patients With Amyotrophic Lateral Sclerosis (ALS)TerminatedNCT00714220
- A Safety and Efficacy Study of Oral Dimebon in Patients With Mild-To-Moderate Alzheimer's DiseaseCompletedNCT00675623Phase 3
- Study of AAV-GAD Gene Transfer Into the Subthalamic Nucleus for Parkinson's DiseaseTerminatedNCT00643890Phase 2
- Visual Motor CoordinationTerminatedNCT00568243
- Risk Factors for Progressive Supranuclear Palsy (PSP)CompletedNCT00431301
- Confirmation of Self-Reported Incident ALS Cases in the AARP-Diet and Health (AARP-DH) CohortCompletedNCT00377351
- Parkinson's Genes and Environment StudyCompletedNCT00367900
- Exposure to Neurotoxins as Risk Factors for ALSCompletedNCT00340301
- Safety and Efficacy of High Dose, Rapid Titration Galantamine in Patients With Alzheimer's DiseaseCompletedNCT00338117Phase 3
- Biodistribution and Safety of a Radiopharmaceutical in Healthy SubjectsCompletedNCT00316797Phase 1
- Magnetic Resonance Imaging (MRI) of Brain Iron in Neurodegenerative DiseaseCompletedNCT00249080
- A Pilot Study of Curcumin and Ginkgo for Treating Alzheimer's DiseaseCompletedNCT00164749Phase 1/2
- Clinical and Genetic Study of Neurodegenerative Disorders With Cognitive ImpairmentCompletedNCT00149175
- Biological Markers in Parkinson's DiseaseCompletedNCT00088335
- Catechol Thioethers in Parkinson's DiseaseCompletedNCT00042692
- Cause and Pathogenesis of Neurometabolic DisordersCompletedNCT00016562
- Continuously Infused Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (GDNF) to Treat Progressive Supranuclear PalsyCompletedNCT00005903Phase 2
- Dextromethorphan for the Treatment of Parkinson's Disease and Similar Conditions of the Nervous SystemCompletedNCT00001365Phase 2